Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions

Key Features

Contains up-to-date reviews of the most important emerging cardiovascular therapies written by world leaders in the field


Pharmacologists, immunologists, and biochemists.

Table of Contents

  1. Ryanodine Receptors in Cardiac Physiology and Disease - Andrew Marks and Alexander Kushnir
  2. Neuregulin-1/ErbB Signaling and Chronic Heart Failure - Yabei Xu, Xinyan Li, Xifu Liu, and Mingdong Zhou
  3. If Inhibition in Cardiovascular Diseases - Catherine Thollon and Jean-Paul Vilaine
  4. Pharmacology of Cardiac Potassium Channels - Gui-Rong Li and Ming-Qing Dong
  5. Beta3-Adrenergic Receptors in Cardiac and Vascular Tissues: Emerging Concepts and Therapeutic Perspectives - Chantal Dessy and Jean-Luc Balligand
  6. Modulation of Vascular Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) in Cardiovascular Pathophysiology - Takeshi Ken Adachi
  7. Advances in the Renin Angiotensin System: Focus on Angiotensin Converting Enzyme 2 and Angiotensin-(1-7) - Carlos M. Ferrario and Jewell Jessup
  8. The Role of Calpain in Diabetes-associated Platelet Hyperactivation - Voahanginirina Randriamboavonjy and Ingrid Fleming
  9. Tissue Factor and Cardiovascular Disease - Erik Holy and Felix C. Tanner


No. of pages:
© 2010
Academic Press
eBook ISBN:
Print ISBN:

About the series-volume-editor